JPMorgan downgrades Clorox, says rising costs will drag down earnings in the year ahead
[ad_1]
Clorox beat estimates for its fiscal first quarter, however its outlook carries dangers, in response to JPMorgan.
[ad_2]
[ad_1]
Clorox beat estimates for its fiscal first quarter, however its outlook carries dangers, in response to JPMorgan.
[ad_2]